• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Role of immunohistochemistry and apoptosis as investigative tools in assessing the prognosis of patients with prostate tumours.免疫组织化学和细胞凋亡作为评估前列腺肿瘤患者预后的研究工具的作用。
Exp Ther Med. 2010 Mar;1(2):391-393. doi: 10.3892/etm_00000061. Epub 2010 Mar 1.
2
Relationship between apoptosis regulator proteins (bcl-2 and p53) and Gleason score in prostate cancer.前列腺癌中凋亡调节蛋白(bcl-2和p53)与Gleason评分之间的关系
Pathol Oncol Res. 2001;7(3):209-12. doi: 10.1007/BF03032351.
3
Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers.前列腺癌中bcl-2、bax、bcl-X和mcl-1表达的免疫组织化学分析
Am J Pathol. 1996 May;148(5):1567-76.
4
Expression of Bcl-2, Bax, and p53 in high-grade prostatic intraepithelial neoplasia and localized prostate cancer: relationship with apoptosis and proliferation.Bcl-2、Bax和p53在高级别前列腺上皮内瘤变和局限性前列腺癌中的表达:与细胞凋亡和增殖的关系。
Prostate. 1998 Dec 1;37(4):223-9. doi: 10.1002/(sici)1097-0045(19981201)37:4<223::aid-pros3>3.0.co;2-o.
5
Prognostic value of DNA ploidy, bcl-2 and p53 in localized prostate adenocarcinoma incidentally discovered at transurethral prostatectomy.经尿道前列腺切除术中偶然发现的局限性前列腺腺癌中DNA倍体、bcl-2和p53的预后价值。
J Urol. 2006 Dec;176(6 Pt 1):2701-5. doi: 10.1016/j.juro.2006.07.133.
6
Tumour grade, proliferation, apoptosis, microvessel density, p53, and bcl-2 in prostate cancers: differences between tumours located in the transition zone and in the peripheral zone.前列腺癌中的肿瘤分级、增殖、凋亡、微血管密度、p53和bcl-2:移行区和外周区肿瘤之间的差异
Eur Urol. 2002 Jan;41(1):40-6. doi: 10.1016/s0302-2838(01)00021-5.
7
Angiogenesis, p53, bcl-2 and Ki-67 in the progression of prostate cancer after radical prostatectomy.前列腺癌根治术后血管生成、p53、bcl-2和Ki-67在前列腺癌进展中的作用
Eur Urol. 1999;35(5-6):399-407. doi: 10.1159/000019916.
8
Androgen receptor expression in relation to apoptosis and the expression of cell cycle related proteins in prostate cancer.雄激素受体表达与前列腺癌细胞凋亡及细胞周期相关蛋白表达的关系
Pathol Oncol Res. 2004;10(1):37-41. doi: 10.1007/BF02893407. Epub 2004 Mar 18.
9
Detection of apoptosis by the TUNEL technique in clinically localised prostatic cancer before and after combined endocrine therapy.通过TUNEL技术检测临床局限性前列腺癌在联合内分泌治疗前后的细胞凋亡情况。
J Clin Pathol. 1997 May;50(5):384-8. doi: 10.1136/jcp.50.5.384.
10
Correlation between histological type and immunohistochemical profile of prostate cancer and gleason scale gradation.前列腺癌的组织学类型、免疫组化特征与 Gleason 分级之间的相关性。
Exp Oncol. 2009 Dec;31(4):246-9.

本文引用的文献

1
Prostate carcinoma presentation, diagnosis, and staging: an update form the National Cancer Data Base.前列腺癌的临床表现、诊断及分期:来自美国国立癌症数据库的最新信息
Cancer. 2003 Sep 15;98(6):1169-78. doi: 10.1002/cncr.11635.
2
p53 protein overexpression is associated with increased cell proliferation in patients with locally recurrent prostate carcinoma after radiation therapy.p53蛋白过表达与局部复发性前列腺癌患者放疗后细胞增殖增加有关。
Cancer. 1999 Mar 15;85(6):1293-9.
3
Prognostic significance of Ki-67, p53, and Bcl-2 expression in prostate cancer patients with lymph node metastases: a retrospective immunohistochemical analysis.Ki-67、p53和Bcl-2表达在伴有淋巴结转移的前列腺癌患者中的预后意义:一项回顾性免疫组织化学分析
Pathol Int. 1998 Jan;48(1):41-6. doi: 10.1111/j.1440-1827.1998.tb03826.x.
4
Locally recurrent prostate tumors following either radiation therapy or radical prostatectomy have changes in Ki-67 labeling index, p53 and bcl-2 immunoreactivity.无论是放射治疗还是根治性前列腺切除术后出现的局部复发性前列腺肿瘤,其Ki-67标记指数、p53和bcl-2免疫反应性均有变化。
J Urol. 1998 May;159(5):1437-43. doi: 10.1097/00005392-199805000-00004.
5
Combined analysis with Bcl-2 and P53 immunostaining predicts poorer prognosis in prostatic carcinoma.
J Urol. 1997 Dec;158(6):2278-83. doi: 10.1016/s0022-5347(01)68235-1.
6
Molecular markers for prostate cancer metastasis. Developing diagnostic methods for predicting the aggressiveness of prostate cancer.前列腺癌转移的分子标志物。开发预测前列腺癌侵袭性的诊断方法。
Am J Pathol. 1997 May;150(5):1511-21.
7
p53, the cellular gatekeeper for growth and division.p53,细胞生长和分裂的守门人。
Cell. 1997 Feb 7;88(3):323-31. doi: 10.1016/s0092-8674(00)81871-1.
8
Extent of apoptosis in relation to p53 and bcl-2 expression in germ cell tumors.生殖细胞肿瘤中凋亡程度与p53和bcl-2表达的关系
Hum Pathol. 1996 Nov;27(11):1221-6. doi: 10.1016/s0046-8177(96)90318-4.
9
Elevated levels of apoptosis regulator proteins p53 and bcl-2 are independent prognostic biomarkers in surgically treated clinically localized prostate cancer.凋亡调节蛋白p53和bcl-2水平升高是手术治疗的临床局限性前列腺癌的独立预后生物标志物。
J Urol. 1996 Oct;156(4):1511-6.
10
The biologic dilemma of early carcinoma of the prostate.前列腺早期癌的生物学困境
Cancer. 1996 Jul 15;78(2):326-9. doi: 10.1002/(SICI)1097-0142(19960715)78:2<326::AID-CNCR21>3.0.CO;2-X.

免疫组织化学和细胞凋亡作为评估前列腺肿瘤患者预后的研究工具的作用。

Role of immunohistochemistry and apoptosis as investigative tools in assessing the prognosis of patients with prostate tumours.

作者信息

Chakravarthi Srikumar, Thani P M, Yang David Low Wee, Husin Linda Tjoa, Lee Nagaraja

机构信息

Departments of Pathology.

出版信息

Exp Ther Med. 2010 Mar;1(2):391-393. doi: 10.3892/etm_00000061. Epub 2010 Mar 1.

DOI:10.3892/etm_00000061
PMID:22993553
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3445942/
Abstract

Apoptosis is a form of programmed cell death necessary for the regulation of the size of organs in adult life. Disruption of apoptotic pathways has been suggested as an important regulatory mechanism in prostatic tumours. The aim of this study was to examine the expression of apoptosis-regulating genes bcl-2 and p53 using immunohistochemistry, and the Gleason score in core needle biopsy specimens of prostate adenocarcinoma. We studied bcl-2 and p53 expression in 30 cases of low-, 30 cases of intermediate- and 20 cases of high-grade prostate adenocarcinoma. Overexpression of bcl-2 and p53 were noted in 54 and 61 of 80 patients (67.5 and 76.25%), respectively. The statistical analysis of the present data suggested that there is significant relation between p53 and bcl-2 expression, and Gleason score in prostate cancer. Thus, immunohistochemistry is a useful investigative parameter in assessing apoptosis to analyse the prognosis of prostatic tumours.

摘要

细胞凋亡是一种程序性细胞死亡形式,对成年期器官大小的调节至关重要。凋亡途径的破坏被认为是前列腺肿瘤的一种重要调节机制。本研究的目的是利用免疫组织化学检测凋亡调节基因bcl-2和p53的表达,以及前列腺腺癌粗针活检标本中的Gleason评分。我们研究了30例低级别、30例中级别和20例高级别前列腺腺癌中bcl-2和p53的表达。80例患者中分别有54例(67.5%)和61例(76.25%)出现bcl-2和p53的过表达。对当前数据的统计分析表明,前列腺癌中p53和bcl-2的表达与Gleason评分之间存在显著相关性。因此,免疫组织化学是评估细胞凋亡以分析前列腺肿瘤预后的一个有用的研究参数。